Ford et al. (2020) have shown that the pharmacologic inhibition of NADPH oxidase 4 in the proneural subtype of GBM “normalized” CAFs to a quiescent phenotype, resulting in intratumoral CD8+ T cell infiltration and thereby overcoming the CAF-mediated CD8+ T-cell exclusion effect. This evidence concerns the gene CD8A and glioblastoma.